
Juvena W. Loo
Examiner (ID: 18974, Phone: (571)270-1974 , Office: P/2473 )
| Most Active Art Unit | 2473 |
| Art Unit(s) | 2473, 2616, 2416, 2609 |
| Total Applications | 547 |
| Issued Applications | 438 |
| Pending Applications | 1 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12239880
[patent_doc_number] => 20180072744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'HETEROARYL SYK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/817435
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42477
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15817435
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/817435 | HETEROARYL SYK INHIBITORS | Nov 19, 2017 | Abandoned |
Array
(
[id] => 13549045
[patent_doc_number] => 20180326070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 15/817473
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15817473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/817473 | CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES | Nov 19, 2017 | Abandoned |
Array
(
[id] => 16326881
[patent_doc_number] => 20200297846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => DIGLYCOSYLATED BENZOPHENOXAZINE PHOTOSENSITIZER AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/763489
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763489
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763489 | Diglycosylated benzophenoxazine photosensitizer and preparation method and use thereof | Nov 15, 2017 | Issued |
Array
(
[id] => 16977598
[patent_doc_number] => 20210221835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => CARBON-MONOXIDE-RELEASING MOLECULES AND THERAPEUTIC APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/487402
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487402
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487402 | Carbon-monoxide-releasing molecules and therapeutic applications thereof | Nov 14, 2017 | Issued |
Array
(
[id] => 15020771
[patent_doc_number] => 20190321390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => SULPHATED HYALURONIC ACIDS FUNCTIONALISED WITH DOPAMINE
[patent_app_type] => utility
[patent_app_number] => 16/344449
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344449
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344449 | Sulphated hyaluronic acids functionalised with dopamine | Nov 12, 2017 | Issued |
Array
(
[id] => 14420045
[patent_doc_number] => 10314808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Aminocarbonylcarbamate compounds
[patent_app_type] => utility
[patent_app_number] => 15/805293
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6301
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15805293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/805293 | Aminocarbonylcarbamate compounds | Nov 6, 2017 | Issued |
Array
(
[id] => 16009173
[patent_doc_number] => 20200179429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/347156
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347156 | Compositions and methods for treating depression | Nov 2, 2017 | Issued |
Array
(
[id] => 14778221
[patent_doc_number] => 20190264008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => Gel Composition and Method for Producing Same
[patent_app_type] => utility
[patent_app_number] => 16/344936
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344936 | Gel Composition and Method for Producing Same | Oct 30, 2017 | Abandoned |
Array
(
[id] => 15571533
[patent_doc_number] => 10576125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Methods for enhancing synaptogenesis and neuritogenesis
[patent_app_type] => utility
[patent_app_number] => 15/796522
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 26159
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796522 | Methods for enhancing synaptogenesis and neuritogenesis | Oct 26, 2017 | Issued |
Array
(
[id] => 14452299
[patent_doc_number] => 10322096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms
[patent_app_type] => utility
[patent_app_number] => 15/793879
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 33530
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15793879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/793879 | Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms | Oct 24, 2017 | Issued |
Array
(
[id] => 12680464
[patent_doc_number] => 20180118654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => Novel N-3 Immunoresolvents: Structures and Actions
[patent_app_type] => utility
[patent_app_number] => 15/793728
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15793728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/793728 | Novel N-3 Immunoresolvents: Structures and Actions | Oct 24, 2017 | Abandoned |
Array
(
[id] => 15492975
[patent_doc_number] => 20200046676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => THERAPEUTIC AGENT FOR NEUROPATHY IN ORGANIC ACIDEMIA OF WHICH MECHANISM RELIES ON INCREASE IN CAMP
[patent_app_type] => utility
[patent_app_number] => 16/341321
[patent_app_country] => US
[patent_app_date] => 2017-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341321 | THERAPEUTIC AGENT FOR NEUROPATHY IN ORGANIC ACIDEMIA OF WHICH MECHANISM RELIES ON INCREASE IN CAMP | Oct 16, 2017 | Abandoned |
Array
(
[id] => 13410149
[patent_doc_number] => 20180256617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES
[patent_app_type] => utility
[patent_app_number] => 15/784869
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15784869
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/784869 | METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES | Oct 15, 2017 | Pending |
Array
(
[id] => 16743515
[patent_doc_number] => 10968490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Labelling compounds and their use in assays
[patent_app_type] => utility
[patent_app_number] => 15/783130
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15391
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783130
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/783130 | Labelling compounds and their use in assays | Oct 12, 2017 | Issued |
Array
(
[id] => 14963053
[patent_doc_number] => 20190309004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => PROCESS FOR PREPARING GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/340163
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340163
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340163 | PROCESS FOR PREPARING GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES | Oct 8, 2017 | Abandoned |
Array
(
[id] => 14624549
[patent_doc_number] => 20190225642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => CRYSTAL OF CYTIDINE DIPHOSPHATE CHOLINE AND PRODUCTION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/339301
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339301 | Crystal of cytidine diphosphate choline and production method thereof | Oct 5, 2017 | Issued |
Array
(
[id] => 15797125
[patent_doc_number] => 20200121705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => METHODS OF TREATING SEPSIS USING ANTI-SEPSIS LIPID A (ASLA) BASED THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 16/339313
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339313
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339313 | Methods of treating sepsis using anti-sepsis lipid A (ASLA) based therapeutics | Oct 3, 2017 | Issued |
Array
(
[id] => 12157212
[patent_doc_number] => 20180028477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'TREATMENT OF CARDIAC REMODELING AND OTHER HEART CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/724117
[patent_app_country] => US
[patent_app_date] => 2017-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14074
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15724117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/724117 | TREATMENT OF CARDIAC REMODELING AND OTHER HEART CONDITIONS | Oct 2, 2017 | Abandoned |
Array
(
[id] => 12138182
[patent_doc_number] => 20180016265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'AMINOESTER DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/718707
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29773
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15718707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/718707 | AMINOESTER DERIVATIVES | Sep 27, 2017 | Abandoned |
Array
(
[id] => 12580545
[patent_doc_number] => 20180085344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => METHOD OF USE OF DITERPENOID DERIVATIVES AS ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/710842
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710842
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/710842 | Method of use of diterpenoid derivatives as anticancer agents | Sep 20, 2017 | Issued |